S&P 500 7,561.67 −0.40%
Nasdaq 25,136.27 −0.91%
S&P/TSX 36,105.90 −0.09%
Apple 356.27 +0.39%
Nvidia 162.85 −2.01%
Microsoft 523.88 +0.17%
Shopify 209.74 +0.16%
Royal Bank 288.37 −0.35%
CAD/USD 0.7008 −0.06%
CLOSED · 23:35 ET
Market ClerkRecap
Sat Nov 14 · markets closed3 signals today368 insider buys this week · $138.2MCIRO short report next: Nov 15The week ahead
GS
INSIDER · 2 COMPANIES · DIRECTOR

George Simeon

Every open-market transaction filed under this name, Sep 28 to Oct 14. The same name appears at more than one issuer; filings don’t say whether it’s one person.

Filings
4
3 buys · 1 sell
Bought
$27.2M
open market, at cost
Sold
$720K
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Oct 14CRSPCRISPR Therapeutics AGDirectorSell14,514$49.63$720K—
Sep 28ADRXADARx Pharmaceuticals, Inc.DirectorBuy592,593$17.00$10.1M—
Sep 28ADRXADARx Pharmaceuticals, Inc.DirectorBuy414,814$17.00$7.1M—
Sep 28ADRXADARx Pharmaceuticals, Inc.DirectorBuy592,593$17.00$10.1M—

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.